Navigation Links
Cynosure Receives Additional International Regulatory Approvals for New Cellulite Reduction Workstations
Date:5/17/2011

WESTFORD, Mass., May 17, 2011 /PRNewswire/ -- Cynosure, Inc. (Nasdaq: CYNO), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced the receipt of two additional international clearances for the Company's new flagship workstations for cellulite reduction.

Cynosure has received regulatory clearance from Australia's Therapeutic Goods Administration (TGA) for its Cellulaze™ Cellulite Laser Workstation, the world's first minimally invasive surgical device for the long-term reduction of cellulite.  The Company also has obtained approval to market its SmoothShapes XV, a non-invasive system for the temporary reduction in the appearance of cellulite, from the Taiwan Food and Drug Administration (TFDA).  Cynosure plans to sell these products through its independent distributors in each country.

"Australia and the Asia Pacific are important and attractive markets for Cynosure as we focus on expanding the international reach of our newest products, particularly our cellulite platform," said President and Chief Executive Officer Michael Davin.  "Consumer demand for aesthetic procedures in these countries is strong, and practitioners are eager to integrate new technologies capable of providing safe, efficacious treatments that result in high levels of patient satisfaction.  We are encouraged about the prospects for Cellulaze and SmoothShapes XV as we grow their distribution channels and build global product recognition."

Cellulaze and SmoothShapes XV have received CE Mark certification in the European Union. SmoothShapes XV also is cleared for marketing in the United States.

Cellulaze, which uses laser thermal energy to target cellulite beneath the surface of the skin, is designed to restore the skin's normal structure and underlying connective tissue. A recently presented clinical study demonstrated the potential of Cellulaze's minimally invasive, sidelight three-dimensional optical fiber and 1440 nm Nd:YAG laser in delivering long-lasting benefits for the treatment of cellulite.  The condition is marked by dimply herniations and depressions within the layers of the skin, typically on the waist, buttocks and thighs.  Cellulite affects an estimated 85 percent of women over age 20(1).

The SmoothShapes XV system treats cellulite through a proprietary process known as Photomology®, which combines laser and light energy with mechanical manipulation (vacuum and massage) to produce tighter, smoother-looking skin.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis and reduce the appearance of cellulite.  Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.  For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.

Forward-Looking Statements

Any statements in this press release about future expectations, plans and prospects for Cynosure, Inc., as well as other statements containing the words "believes," "anticipates," "plans," "expects," "will" and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995.  Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the global economy and lending environment and their effects on the aesthetic laser industry, Cynosure's history of operating losses, its reliance on sole source suppliers, the inability to accurately predict the timing or outcome of regulatory decisions, changes in consumer preferences, competition in the aesthetic laser industry, economic, market, technological and other factors discussed in Cynosure's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, which are filed with the Securities and Exchange Commission.  In addition, the forward-looking statements included in this press release represent Cynosure's views as of the date of this press release.  Cynosure anticipates that subsequent events and developments will cause its views to change.  However, while Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing Cynosure's views as of any date subsequent to the date of this press release.

(1) Rawlings, A.V. Cellulite and its treatment. Int. J. Cosmet. Sci. 28, 175–190 (2006).

Contact:

Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
Phone: (617) 542-5300
cyno@investorrelations.com


'/>"/>
SOURCE Cynosure, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation
2. Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
3. Cynosure to Announce Third-Quarter 2009 Financial Results on October 27
4. Romeo and Juliette Laser Hair Removal Is First Center in New York City to Own Cynosures New Elite MPX(TM) Laser System
5. Cynosure to Present at UBS Global Life Sciences Conference
6. Cynosure to Host Third-Quarter 2010 Financial Results Conference Call on October 26
7. Cynosure to Present at 4th Annual Maxim Group Growth Conference
8. Cynosure Introduces Cellulaze, the Worlds First Aesthetic Laser Device for the Long-Term Reduction of Cellulite
9. Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products
10. Cynosure to Present at 10th Annual Needham Healthcare Conference
11. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... May 24, 2016 Een app ... zodat zij collectief patiënten kunnen behandelen, hun kennis kunnen ... idee achter de nieuwe en revolutionaire MDLinking App, ontwikkeld ... Nederlandse vaatchirurg dr. Hans Flu en oncologisch chirurg dr. ... inmiddels beschikbaar is, wordt op dinsdag 24 mei officieel ...
(Date:5/23/2016)... FLINT, Mich. , May 23, 2016 Diplomat ... the third annual Fellowship and Internship programs. The hands-on ... 12. The full-time, paid Fellowship ... Flint, Michigan . Fellows and interns are ... downtown Flint at the Riverfront ...
(Date:5/23/2016)... , May 23, 2016 ... Devices, Diagnostics and Monitoring, and Vision Care ... Which areas are going to grow at the fastest ... revenues to 2026, assessing data, trends, opportunities and prospects. ... charts, and graphs. Discover the most lucrative areas in ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... 25, 2016 , ... Casa Velas, an adults-only boutique hotel in Puerto Vallarta, ... its new wellness suites . The two 1,350 sq. ft. suites which debuted ... services and insuite amenities, from a custom soap selection and in-suite exercise kit to ...
(Date:5/25/2016)... , ... May 25, 2016 , ... America Walks ... Carol Reichbaum, M.S.L., M.S.P.A., of the University of Pittsburgh Graduate School of Public ... will enable Ms. Reichbaum and 24 other advocates from around the country to participate ...
(Date:5/25/2016)... ... May 25, 2016 , ... "FCPX LUT Intense allows ... your footage," said Christina Austin - CEO of Pixel Film Studios. , With ... and easily add stylish color grades to their footage. A LUT is a Lookup ...
(Date:5/25/2016)... ... May 25, 2016 , ... Consumer access to organic foods ... 2016, Kashi®, a maker of whole grain cereals and other plant-based foods, will introduce ... hard red winter wheat processed by Hesco/Dakota Organic Products. , The transitional designation ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... Stern ... firm will be selling the device branded as Stern’s Real Time Monitoring ... to bedbugs to the hotel and motel industry, colleges for use in dormitories, shelters, ...
Breaking Medicine News(10 mins):